Finance

Lists
BLTE:NASDAQ
Belite Bio Inc
US$156,08
+0,30%
(+0,47) 1D
US$156,08
0,00% (0,00)
After hours
Closed: 7 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
US$155,09
High
US$156,75
Low
US$154,60
Mkt. cap
6,29 ຕື້
Avg. vol.
195,27 ພັນ
Volume
96,77 ພັນ
52-wk high
US$200,00
52-wk low
US$76,50
EPS
US$-2,85
Beta
-1,23
Shares outstanding
40,27 ລ້ານ
No. of employees
41
Open
US$155,09
High
US$156,75
Low
US$154,60
Mkt. cap
6,29 ຕື້
Avg. vol.
195,27 ພັນ
Volume
96,77 ພັນ
52-wk high
US$200,00
52-wk low
US$76,50
EPS
US$-2,85
Beta
-1,23
Shares outstanding
40,27 ລ້ານ
No. of employees
41
News stories
From web sources and news partners
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Analyst ratings
Based on 7 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current US$156,08
US$303,00 (+94,13%)
Average
US$236,86 (+51,76%)
Lowest
US$200,00 (+28,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
US$234,00
+49,9%
09/09/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$245,00
+57%
09/09/2026
Whitney Ijem
Canaccord Genuity
Buy
Initiated
US$303,00
+94,1%
09/04/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
US$200,00
+28,1%
09/02/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
US$206,00
+32%
08/17/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
US$200,00
+28,1%
08/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$270,00
+73%
08/14/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
US$217,00
+39%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,31 ລ້ານ
14,62 ລ້ານ
15,66 ລ້ານ
18,21 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,71 ລ້ານ
13,45 ລ້ານ
17,02 ລ້ານ
16,69 ລ້ານ
Operating expense
23,02 ລ້ານ
28,08 ລ້ານ
32,68 ລ້ານ
34,91 ລ້ານ
Total operating expenses
23,02 ລ້ານ
28,08 ລ້ານ
32,68 ລ້ານ
34,91 ລ້ານ
Operating income
-23,02 ລ້ານ
-28,08 ລ້ານ
-32,68 ລ້ານ
-34,91 ລ້ານ
Other non operating income
-2,14 ລ້ານ
-417,00 ພັນ
5,75 ລ້ານ
6,55 ລ້ານ
EBT including unusual items
-21,69 ລ້ານ
-25,32 ລ້ານ
-26,94 ລ້ານ
-28,36 ລ້ານ
EBT excluding unusual items
-21,69 ລ້ານ
-25,32 ລ້ານ
-26,94 ລ້ານ
-28,36 ລ້ານ
Income tax expense
-
-
-
55,00 ພັນ
Effective tax rate
-
-
-
-0,19%
Other operating expenses
-
-
-
-
Net income
-21,69 ລ້ານ
-25,32 ລ້ານ
-26,94 ລ້ານ
-28,41 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,65
-0,70
-0,68
-0,70
Interest and investment income
3,47 ລ້ານ
3,17 ລ້ານ
-
-
Interest expense
-
-2,00 ພັນ
-
-
Net interest expenses
3,47 ລ້ານ
3,17 ລ້ານ
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,97 ລ້ານ
-28,03 ລ້ານ
-32,64 ລ້ານ
-34,86 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google